Moreover, we observed that the expression of ABCB6, FLVCR1 and SLC7A11 in erastin-treated tumor tissues was significantly lower than that in vehicle-treated tumor tissues, but there was no significant difference in the expression of SLC48A1 between the two groups (Fig. 11g). Here, SLC48A1 is linked to neoplasm.